Biopolymer Based Implantable Degradable Devices

• US 20100172953A1
• Filed: 06/13/2008
• Published: 07/08/2010
• Est. Priority Date: 06/13/2007
• Status: Abandoned Application

• Current Assignee: FMC Corporation
• Original Assignee: FMC Corporation
• Inventors: Andersen, Therese, Larsen, Christian Klein
• Application Number:
  US12/663,591
• Publication Number:
  US 20100172953A1
• Time in Patent Office: Days
• US Class Current: 424/423
• CPC Class Codes: A61L 31/042 Polysaccharides
• CPC Class Codes: A61L 31/14 Materials characterised by their function or physical properties , e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
• CPC Class Codes: A61L 31/148 Materials at least partially resorbable by the body
• CPC Class Codes: A61P 19/04 for non-specific disorders of the connective tissue
• CPC Class Codes: A61P 43/00 Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Implantable degradable devices for tissue repair or reconstruction comprising biopolymers, as well as to methods of manufacture and use thereof. The implantable device is formed by the application of pressure and the device may include up to about 65% by weight of water, based on the total weight of the implantable degradable fastening device. Methods for making implantable, degradable devices from biopolymers by application of pressure are also disclosed. The invention provides the ability to customize the device in various ways to influence properties such as mechanical strength, degradation rate and swellability.

Claims

1. An implantable degradable device suitable for use in tissue repair or reconstruction comprising at least one biopolymer, wherein said implantable device is pre-shaped by the application of pressure and said device comprises up to about 65% by weight of water, based on the total weight of the implantable degradable device.

2. The device of claim 1, wherein said biopolymer comprises a polysaccharide.

3. The device of claim 2, wherein said biopolymer comprises at least one of alginate, chitosan, and hyaluronate, modified polysaccharides, and mixtures thereof.

4. The device of claim 3, wherein said device is a screw, pin, bolt, anchor, rod, or plug.

5. The device of claim 1, wherein the biopolymer is not substantially ionically crosslinked.

6. The device of claim 1, wherein said device further comprises at least one material selected from the group consisting of plasticizers, at least one non-degradable biopolymer, uncrosslinked degradation controlling agents, imaging agents, pharmaceutically active agents, tissue regenerative agents, cell adhesion peptide sequences and growth factor agents.

7. The device of claim 2, wherein said device comprises at least one coating.

8. The device of claim 7, wherein said coating comprises at least one material selected from the group consisting of degradable biopolymers, imaging agents, pharmaceutically active agents, tissue regenerative agents, tissue adhesive agents, cell adhesion peptide sequences and growth factor agents.

9. The device of claim 8, wherein said coating comprises at least one material selected from the group consisting of sustained release agents, immediate release agents and delayed release agents.

10. The device of claim 1, wherein said device comprises a water:

biopolymer ratio of 2;

10 to 0.01;

10.

11. The device of claim 1, wherein said device comprises a water:

biopolymer ratio of 1.5;

10 to 0.5;

10.

12. The device of claim 1, wherein said biopolymer comprises at least one cationic biopolymer and at least one anionic biopolymer.

13. The device of claim 1, comprising at least one biopolymer fiber.

14. The device of claim 1, wherein at least a portion of said device is filled with a biopolymer hydrogel component.

15. The device of claim 14, wherein said biopolymer hydrogel component comprises a material selected from the group consisting of alginate, chitosan, hyaluronate, modified polysaccharides and mixtures thereof.

16. The device of claim 14, wherein said biopolymer hydrogel component further comprises at least one material selected from the group consisting of:

imaging agents, pharmaceutically active agents, tissue regenerative agents, tissue adhesive agents, cell adhesion peptide sequences, growth factor agents and cells.

17. The device of claim 1, wherein said device has a density of from about 0.6 to about 1.5 mg/cm³.

18. Use of the device of claim 1 as a fixation device.

19. Use of the device of claim 1 as a drug delivery vehicle.

20. Use of the device of claim 1 as a scaffold for tissue growth.

21. A method of making an implantable degradable device suitable for use in tissue repair or reconstruction, as claimed in any one of claims 1-17 comprising the step of forming the device by application of pressure to a biopolymer-containing material.

22. The method of claim 21, wherein the pressure is applied to a biopolymer-containing material which contains at least 35% by weight of biopolymer, based on the total weight of the biopolymer-containing material.

23. The method of claim 22, wherein sufficient pressure is applied to a partially hydrated biopolymer-containing material to produce a homogeneous biopolymer-containing material that is more transparent after application of pressure than before application of pressure.

24. The method of claim 23, further comprising the step of drying said formed device by application of a drying step selected from air drying and freeze drying.

25. The method of claim 21, wherein said device is formed by at least one of molding, milling and extrusion.

26. The method of claim 21, further comprising the step of treating the formed device in an aqueous bath comprising at least one material selected from the group consisting of:

plasticizers, degradable biopolymers, uncrosslinked degradation control agents, imaging agents, tissue adhesion agents, cell adhesion peptide sequences and growth factors, to form at least a partial coating on said device.

27. The method of claim 26, wherein said coating further comprises at least one material selected from the group consisting of sustained release agents, immediate relate agents and delayed release agents.

28. The method of claim 21, wherein said biopolymer-containing material comprises a cationic biopolymer and an anionic biopolymer and said method further comprises the step of determining a ratio of said cationic biopolymer to said anionic biopolymer contained in said biopolymer-containing material to control a rate of erosion, swelling and/or degradation of said device when implanted in a body.